News
New York Magazine on MSN7d
What It’s Like to Be a Vaccine Researcher in RFK Jr.’s AmericaHe is the head of HHS, and yet he continues to spout untested, unproven therapies and has only given a very lukewarm ...
Vaccines have been a central focus for Trump's health leaders, but large-cap players aren't feeling the sting.
Such a change would put the U.S. more in line with guidance in other countries and with the World Health Organization, which ...
Moderna MRNA is expected to report first-quarter 2025 earnings on May 1, before the opening bell. The company’s earnings beat ...
Jenny Strasburg is a reporter in London, where she writes for The Wall Street Journal about oil and gas, climate, the ...
MedPage Today on MSN5d
Rotavirus Vaccines Involve Several Special ConsiderationsThere are two vaccines approved by the FDA -- RotaTeq and Rotarix -- that protect against rotavirus, the most common cause of ...
Advancements in mRNA vaccine technology are reshaping medicine, addressing challenges and expanding applications from COVID-19 to personalized cancer therapies.
In the first meeting of the Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices (ACIP) ...
Peter Loftus is a reporter for The Wall Street Journal in Philadelphia covering the pharmaceutical and medical-device ...
Novavax said on Wednesday U.S. regulators asked the company to produce more data on its COVID-19 vaccine if it gets full ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback